news

February 13, 2020

Thermo Fisher Scientific Introduces NGS-Based Solution for Expanded Carrier Screening Research

Thermo Fisher Scientific has introduced a new next-generation sequencing (NGS)-based solution that enables reproductive health researchers to more efficiently analyze a broad range of... Read More
February 4, 2020

Bicameral, Bipartisan Group of Lawmakers Form Congressional Personalized Medicine Caucus

The Personalized Medicine Coalition (PMC) today announces its support for a new bicameral, bipartisan Congressional Personalized Medicine Caucus formed by Sens. Tim Scott (R-SC)... Read More
January 22, 2020

Governor Cooper Announces over 460 Jobs in Durham as Eli Lilly and Company Selects North Carolina for Major Pharmaceutical Plant

Eli Lilly and Company (NYSE: LLY), a global healthcare and biopharmaceutical company, will invest over $470 million and create more than 460 new jobs... Read More
January 22, 2020

Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has acquired Blueprint Genetics in an all-cash equity... Read More
January 15, 2020

LabCorp to Adopt Thermo Fisher Scientific’s Ion Torrent Genexus Next-Generation Sequencing System and Pan-Cancer Assay for Use in Oncology Research and Development

LabCorp® (NYSE: LH) announced it will adopt the Ion Torrent Genexus System* and Oncomine Precision Assay* for use in research and development of companion... Read More
January 14, 2020

Dr. Thomas J. Lynch Jr. named new president and director of Fred Hutch

Dr. Thomas J. Lynch Jr. will become Fred Hutchinson Cancer Research Center’s new president and director, the organization announced today. Lynch, a well-known cancer... Read More
January 13, 2020

Thermo Fisher Scientific Opens $90 Million Viral Vector Manufacturing Site in Massachusetts

Thermo Fisher Scientific Inc., the world leader in serving science, officially opened its new $90 million viral vector CDMO (contract development and manufacturing organization)... Read More
January 13, 2020

Roche and Illumina partner to broaden patient access to genomic testing

Roche has announced that it has entered into a 15-year, non-exclusive partnership with Illumina to broaden the adoption of distributable next-generation sequencing (NGS) based... Read More
December 12, 2019

Michael Rivers, Head of Roche Digital Pathology, named president of Digital Pathology Association

Michael Rivers, Vice President, Roche Digital Pathology, has been named president of the Digital Pathology Association (DPA), effective Jan. 1, 2020. The DPA is... Read More
December 12, 2019

Thermo Fisher Scientific to Bring One-Day Genomic Profiling to Hematology Oncology

Clinical researchers who take a traditional sequential approach to analyze myeloid malignancies, a highly heterogeneous group of disorders, face a major hurdle: a laborious... Read More
November 21, 2019

Bristol-Myers Squib and Pfizer Announce, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals

The Bristol-Myers Squibb-Pfizer Alliance today announced the initiation of a new randomized, controlled study, GUARD-AF (ReducinG stroke by screening for UndiAgnosed atRial fibrillation in... Read More
November 21, 2019

Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company

Bristol-Myers Squibb Company (NYSE:BMY) has announced that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all... Read More
November 21, 2019

Massive Bio and The American Sexual Health Association Partner to Increase Patient Access to Cervical Cancer Clinical Trials

Massive Bio, a leader in Artificial Intelligence (AI) based oncology clinical trial enrollment, and The American Sexual Health Association (ASHA), a leader in advancing... Read More
November 21, 2019

Quality Cancer Care Alliance Network (QCCA) Selects Integra Connect as Preferred Population Health Analytics Partner

Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced it has been selected by the Quality Cancer Care... Read More
November 20, 2019

Thermo Fisher Scientific Introduces First Next-Generation Sequencing Platform That Delivers Specimen to Report in a Single Day

Thermo Fisher Scientific announced the launch of its Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform featuring an automated specimen-to-report... Read More
MORE NEWS